A number of stocks fell in the afternoon session after a surprisingly hot wholesale inflation report fueled investor concerns about persistent price pressures. The Producer Price Index (PPI), a key ...

GoodRx Holdings, Inc. recently reported fourth-quarter 2025 revenue of US$194.79 million and full-year revenue of US$796.85 million, alongside the launch of GoodRx Employer Direct to help employers ...

TrumpRx is primarily for people who pay for their prescriptions out-of-pocket. There may be cheaper generic options at direct ...

GoodRx projects Pharma Direct revenue to grow at least 30% year-over-year in 2026. Management anticipates continued acceleration in condition-specific subscriptions launched in late 2025, with weight ...

GoodRx Holdings, Inc. ( GDRX) Q4 2025 Earnings Call February 26, 2026 8:00 AM EST Ladies and gentlemen, thank you for standing by, and welcome to the GoodRx Fourth Quarter and Full Year 2025 Earnings ...

The Trump administration's new website, TrumpRx, is a poor imitation of GoodRx with fewer options, and does not provide real relief for families struggling with high drug prices.

The Trump administration’s new website, TrumpRx, is a poor imitation of GoodRx with fewer options, and does not provide real ...

Fourth Quarter and Full Year 2025 Revenue and Adjusted EBITDA Results In-line with Previous Guidance Pharma Direct Revenue Beats Previous Outlook with Over 40% Year-Over-Year Growth for 2025SANTA ...

There's been a flurry of recent activity in the direct-to-consumer space as drug costs and spending continues to rise. | LOS ...

The list price of Wegovy will be cut in half on January 1, 2027, plummeting from around $1,350 to $675 a month. The cost of ...

What Happened? A number of stocks fell in the morning session after the Trump administration's announcement of new global ...

Q. My husband got COVID last fall. He has had great success from Paxlovid in the past, when he got it for free during the pandemic. This time he was charged $800 on his Medicare Drug Plan. That seems ...